Créange A - Search Results

1

Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.

Nicoletti F, Créange A, Orlikowski D, Bolgert F, Mangano K, Metz C, Di Marco R, Al Abed Y. Nicoletti F, et al. Among authors: creange a. J Neuroimmunol. 2005 Nov;168(1-2):168-74. doi: 10.1016/j.jneuroim.2005.07.019. J Neuroimmunol. 2005. PMID: 16171874 Clinical Trial.

2

Inhibition of the adhesion step of leukodiapedesis: a critical event in the recovery of Guillain-Barré syndrome associated with accumulation of proteolytically active lymphocytes in blood.

Créange A, Chazaud B, Sharshar T, Plonquet A, Poron F, Eliezer MC, Raphaël JC, Gherardi RK. Créange A, et al. J Neuroimmunol. 2001 Mar 1;114(1-2):188-96. doi: 10.1016/s0165-5728(00)00465-3. J Neuroimmunol. 2001. PMID: 11240031

3

Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.

Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphaël JC, Gherardi RK, Créange A. Orlikowski D, et al. Among authors: creange a. J Neuroimmunol. 2003 Jan;134(1-2):118-27. doi: 10.1016/s0165-5728(02)00393-4. J Neuroimmunol. 2003. PMID: 12507779

4

Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.

Créange A, Bélec L, Clair B, Raphaël JC, Gherardi RK. Créange A, et al. J Neuroimmunol. 1996 Aug;68(1-2):95-9. doi: 10.1016/0165-5728(96)00075-6. J Neuroimmunol. 1996. PMID: 8784265

5

[Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?].

Créange A, Sharshar T, Raphaël JC, Gherardi R. Créange A, et al. Rev Neurol (Paris). 2002 Jan;158(1):15-27. Rev Neurol (Paris). 2002. PMID: 11938319 Review. French.

6

Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.

Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H. Rolland A, et al. Among authors: creange a. J Neuroimmunol. 2005 Mar;160(1-2):195-203. doi: 10.1016/j.jneuroim.2004.10.019. Epub 2004 Dec 8. J Neuroimmunol. 2005. PMID: 15710473

7

Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Wakerley BR, Uncini A, Yuki N; GBS Classification Group; GBS Classification Group. Wakerley BR, et al. Nat Rev Neurol. 2014 Sep;10(9):537-44. doi: 10.1038/nrneurol.2014.138. Epub 2014 Jul 29. Nat Rev Neurol. 2014. PMID: 25072194 Review.

8

Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome.

Créange A, Sharshar T, Planchenault T, Christov C, Poron F, Raphaël JC, Gherardi RK. Créange A, et al. Neurology. 1999 Nov 10;53(8):1683-91. doi: 10.1212/wnl.53.8.1683. Neurology. 1999. PMID: 10563613

9

Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome.

Plonquet A, Gherardi RK, Créange A, Antoine JC, Benyahia B, Grisold W, Drlicek M, Dreyfus P, Honnorat J, Khouatra C, Rouard H, Authier FJ, Farcet JP, Delattre JY, Delfau-Larue MH. Plonquet A, et al. Among authors: creange a. J Neuroimmunol. 2002 Jan;122(1-2):100-5. doi: 10.1016/s0165-5728(01)00452-0. J Neuroimmunol. 2002. PMID: 11777548

10

Guillain-Barré syndrome: 100 years on.

Créange A. Créange A. Rev Neurol (Paris). 2016 Dec;172(12):770-774. doi: 10.1016/j.neurol.2016.10.011. Epub 2016 Nov 17. Rev Neurol (Paris). 2016. PMID: 27866731 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page